You are here

Article info

Article menu

Download PDFPDF

Poster presentations
103
OUTCOMES OF DOSE ESCALATION WITH ADALIMUMAB (ADA) IN INFLAMMATORY BOWEL DISEASE
Free

Authors

  • A Dillon Centre for Colorectal Disease, St Vincent's University Hospital and School of Medicine and Medical Science, University College Dublin, Ireland PubMed articlesGoogle scholar articles
  • C Rowan Centre for Colorectal Disease, St Vincent's University Hospital and School of Medicine and Medical Science, University College Dublin, Ireland PubMed articlesGoogle scholar articles
  • D Gibson Centre for Colorectal Disease, St Vincent's University Hospital and School of Medicine and Medical Science, University College Dublin, Ireland PubMed articlesGoogle scholar articles
  • D Keegan Centre for Colorectal Disease, St Vincent's University Hospital and School of Medicine and Medical Science, University College Dublin, Ireland PubMed articlesGoogle scholar articles
  • K Byrne Centre for Colorectal Disease, St Vincent's University Hospital and School of Medicine and Medical Science, University College Dublin, Ireland PubMed articlesGoogle scholar articles
  • H Mulcahy Centre for Colorectal Disease, St Vincent's University Hospital and School of Medicine and Medical Science, University College Dublin, Ireland PubMed articlesGoogle scholar articles
  • G Cullen Centre for Colorectal Disease, St Vincent's University Hospital and School of Medicine and Medical Science, University College Dublin, Ireland PubMed articlesGoogle scholar articles
  • G Doherty Centre for Colorectal Disease, St Vincent's University Hospital and School of Medicine and Medical Science, University College Dublin, Ireland PubMed articlesGoogle scholar articles

Citation

Dillon A, Rowan C, Gibson D, et al
OUTCOMES OF DOSE ESCALATION WITH ADALIMUMAB (ADA) IN INFLAMMATORY BOWEL DISEASE
Gut 2013;62:A42-A43.

Publication history

  • First published June 8, 2013.
Online issue publication 
March 05, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions